🇺🇸 FDA
Patent

US 12053481

Compositions and methods for deep dermal drug delivery

granted A61KA61K31/519A61K31/585

Quick answer

US patent 12053481 (Compositions and methods for deep dermal drug delivery) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCUTIS BIOTHERAPEUTICS, INC.
Grant date
Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/519, A61K31/585, A61K47/20, A61K47/24